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13C-NMR has been used te follow the metabolism of 13C-enriched substrates in isolated perfused rat liver. 
The fate of 90% enriched [2-13C]acetate has been studied in the perfused liver in order to investigate mito- 
chondrial metabolism and the interrelations between cytosolic and mitochondrial pools of metabolites. 
Some compounds of the intermediary metabolism where found to be extensively labelled, e.g. glutamate, 
glutamine, acetoacetate and /?-hydroxybutyrate. Under our experimental conditions, labelling of glutamate 
reached a steady-state within 30 min after the onset of perfusion of 20 mM acetate. In addition. the observed 
incorporation of 13C into glutamine can be linked to the operation of the glutamate-glutamine antiport and 
to the high activity of cytosolic glutamate synthetase. The finding of both active glutaminase and glutamine 
synthetase activity in the same liver cells is evidence of the existence of an active glutamine-glutamate futile 
cycle. 
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1. INTRODUCTION 
The metabolism of glutamine and glutamate re- 
mains imperfectly understood despite 25 years of 
active research. Many reviews [l-4] have recently 
confirmed the renewed interest in the study of 
these important metabolic pathways; they have 
also revealed a large number of unanswered ques- 
tions. Among the most relevant issues which are 
still pending, one can quote the control of 
glutamine and glutamate metabolism, the in- 
tracellular compartmentation and physiological 
role of glutamine in the metabolism of normal and 
tumor cells. 
Most of the studies on hepatic metabolism to 
date have been conducted on isolated hepatocytes, 
mitochondria and perfused liver by using the con- 
ventional method of biochemical analysis of the 
perfusate or of freeze-clamped extracts. Recently, 
* To whom correspondence should be addressed 
it has become clear that NMR can give precise in- 
formation on the variation of metabolite levels and 
fluxes through biochemical pathways in a non- 
invasive manner and in real time [5,6]. 3’P- and 
13C-NMR have been applied to study hepatic 
metabolism on various biological systems in- 
cluding isolated rat hepatocytes [7,8] and 
mitochondria [9, lo], perfused mouse and rat livers 
[11,12]andliverofwholerat [13,14]. Inrelationto 
the relatively low sensitivity and low natural abun- 
dance of 13C, the majority of the 13C-NMR studies 
on hepatocytes and perfused liver are based on the 
use of 13C-enriched substrates such as glycerol, 
alanine and pyruvate [8,11]. 
Here, we have applied 13C-NMR to follow the 
fate of 90% enriched [2-13C]acetate in perfused rat 
liver in order to investigate the mitochondrial 
metabolism and the interrelations between the 
cytosolic and mitochondrial pools of metabolites. 
As a result of the operation of the Krebs cycle, 
some compounds of the intermediary metabolism 
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were found to be extensively labelled, e.g., glu- 
tamate, glutamine, acetoacetate and P-hydroxy- 
butyrate. Under our experimental conditions we 
have observed a transfer of the label from 
glutamate to glutamine consistent with an 
operative glutamate-glutamine antiport and a high 
activity of cytosolic glutamate synthetase. In addi- 
tion, the finding of both active glutaminase and 
glutamine synthetase in the same liver is in agree- 
ment with the previously reported glutamine- 
glutamate futile cycle [14]. 
2. MATERIALS AND METHODS 
2.1. NMR spectroscopy 
Experiments were performed on a Nicolet 
NT200-WB spectrometer operating at 4.7 T. 13C 
spectra were recorded at 50.3 MHz from rat liver 
preparations perfused in 20-mm diameter tubes. 
Each spectrum corresponds to the Fourier 
transform of 720 free induction decays resulting 
from 4.5” radiofrequency pulses repeated every 
0.5 s. Gated bilevel broad-band proton decoupling 
was used with high-level power (5 W) applied only 
during the acquisition time. 
2.2. Liver perfusion 
Rats of the Wistar strain (60-80 g) were used as 
liver donors and were fed ad libitum. The liver was 
excised under intraperitoneal pentobarbital 
anesthesia (50 mg/kg) and perfused at the rate of 
2-3 ml/min per g liver wet wt. Perfusion was car- 
ried out in the retrograde mode (caval to portal 
vein). The perfusion system consisted of two low 
pulsing peristatic pumps (Gilson), a membrane ox- 
ygenator (Scimed), a pHM73 unit (Radiometer) 
for monitoring the pH, ~02 and pCOz of the per- 
fusate and a multichannel chart recorder (Sefram). 
The perfusion medium was a Krebs-Henseleit 
bicarbonate buffer gassed with 95% 02/5% COZ. 
The perfusate was delivered to the liver at 37°C by 
a water-jacketed system connected to a ther- 
moregulating bath. 
3. RESULTS 
The excised rat liver was perfused in the non- 
recirculating mode with a perfusion medium con- 
taining 10 mM glucose during 30 min to allow for 
temperature equilibration and optimization of 
30 
magnetic field homogeneity. During this period, 
the energetic status of the liver was assessed by 
recording sequential 31P-NMR spectra. A 
background natural abundance 13C spectrum was 
also recorded prior to the addition of the enriched 
substrate. A solution of [2-13C]acetate (1 ml) 
carefully adjusted to pH 7.4 was then added to the 
buffer reservoir to give a concentration of 20 mM 
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Fig. 1. 13C-NMR spectra of isolated rat liver perfused 
with [2-13C]acetate. The liver was perfused with a Krebs- 
Henseleit medium containing 10 mM glucose. (A) 
O-50 ppm region of the natural abundance 13C-NMR 
spectrum from perfused liver. (B) Difference spectrum 
obtained by subtracting the background spectrum (A) 
from the spectrum recorded 6 min after switching the 
perfusate from glucose to glucose plus acetate. (C and 
D) Same as (B) but 36 min and 1 h after the onset of 
acetate perfusion, respectively. GLU, glutamate; GLN, 
glutamine; AC, acetate; AA, acetoacetate; HB, /3- 
hydroxybutyrate. 
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acetate in the perfusate. The perfusion system was 
then switched to the recirculating mode, and the 
time course of acetate utilization was monitored by 
serially recording13C-NMR spectra at 6-min inter- 
vals. An illustration of acetate metabolism as 
followed by ‘%Z-NMR is given in fig. 1. This figure 
shows the natural abundance 13C-NMR spectrum 
of perfused liver from 0 to 50 ppm (fig, IA) and the 
difference spectra obtained 6 min, 36 min and 1 h 
after the onset of acetate perfusion (fig.lB-D). 
The signals appearing in the difference spectra 
correspond to carbon resonances arising from 
labelled metabolites in the liver. They have been 
assigned to specific carbons of metabolites on the 
basis of their chemical shifts and the analysis of 
liver extracts. In the 6 min difference spectrum 
{spectrum B), the intense line at 23.8 ppm cor- 
responds to the signal of [2-13C]acetate, whereas 
the signals at 27.7 and 34.2 ppm arise from C-3 
and C-4 of labelled glutamate, respectively. Ac- 
cumulation of acetoacetate which is expected 
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Fig.2 Time course of 13C incorporation into 
intermediary metabolites in isolated rat liver perfused 
with [Z-“‘C]acetate. ExperjmentaI conditions and 
abbreviations as in fig.1. Ordinates give the relative 
intensities of the signals corresponding to labelled 
metabolites. The arrow indicates the time of acetate 
injection. 
under these experimental conditions is reflected in 
the signal at 30.1 ppm (acetoacetate C-4). As the 
perfusion time with the acetate-containing lucose 
medium increased, other metabolites were Ia- 
belled, giving rise to well-defined resonances in the 
difference spectra (fig. 1C and D). The signals have 
been assigned to ~l~tamine C-4 resonance (32.1 
ppm) and ,8-hydroxybutyrate C-2 (45.4 ppm) and 
C-4 (22.1 ppm) resonances. 
Assuming that the values for the Tr relaxation 
time of all the observed metabolites do not differ 
significantly, the intensities of the signals can be 
considered as directly proportional to the r3C 
enrichment of the molecule. The rate of label in- 
corporation calcutated on the basis of the area of 
the signals is given in fig.2. The data show that 
glutamate at the C-4 position is the first labelted. 
The glutamate C-4 labelling reaches a m~imum 
value after 30 min acetate perfusion, and then 
decreases linearty with time back to 60% of its 
m~imum value after 1 h perfusion. The same pro- 
file is observed for C-2 and C-4 of /Y- 
hydroxybutyrate. In contrast, the labelling of 
gl~tamine C-4 increases with time, After 1 h 
acetate perfusion, the enrichment of glutamine C-4 
is found to be higher than that of the homologous 
carbon in the glutamate molecule. 
4, DISCUSSION 
Transient and steady-state changes induced by 
acetate utilization in perfused rat tiver can be 
directly monitored by 13C-NMR as illustrated in 
fig.2. The rapid isotope enrichment of glutamate 
at the C-4 position can be related to an increase in 
intracellutar glutamate concentration subsequent 
to enhanced Krebs cycle activity. In fact, the total. 
content of Krebs cycle intermediates increases after 
the perfusion of acetate, as a result of the trans- 
amination of part of the aspartate pool into ox- 
aloacetate, under the control of aspartate 
ami~otransferase. The rate of glutamate Iabetting 
can then be interpreted in terms of exchange rate 
across the aspartate-glutamate transamination 
process. It is noteworthy that aspartate is not 
labelled, indicating a very low activity of the 
malate-aspartate shuttle under our experimenta 
conditions. 
The fall in isotopic enrichment of gtutamate C-4 
after 30 min acetate perfusion can be accounted 
31 
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for in terms of isotopic dilution rather than cor- 
responding to a decrease in intracellular glutamate 
concentration. The concomitant labelling of 
glutamine is direct evidence of the existence of an 
electrogenic glutamate-glutamine antiporter, the 
efflux of labelled glutamate through the mitochon- 
drial membrane being coupled with the mitochon- 
dria1 influx of unlabelled cytosolic glutamine. The 
decrease in isotope enrichment of glutamate is 
linked to the activity of the intramitochondrial 
glutaminase leading to deamidation of glutamine 
and a release of unlabelled glutamate into the 
matrix space. 
The kinetics of 13C incorporation presented in 
fig.2 is consistent with a transfer of the (4-r3C) 
from glutamate to glutamine indicating a high 
glutamine synthetase activity, located in the 
cytosolic compartment [151. These results further 
support the idea of the existence of an active 
glutamate-glutamine cycle in the liver [ 16,171. The 
relative contributions of the intracelluIar vs the 
reported intercellular pathway [18] is now under 
investigation. 
ACKNOWLEDGEMENTS 
This work was supported by CNRS (UA 202), 
and grants from INSERM (CRL 813006), 
CNAMTS (CRE 1984-1986), MRI (GBM 83M0802 
and 84M0884) and the Fondation pour la Recher- 
the Medicale. 
LETTERS 
REFERENCES 
June 1985 
121 
[31 
141 
[51 
161 
171 
PI 
[91 
1101 
[Ill 
[=I 
1131 
1141 
tw 
[I61 
1171 
iI81 
Lund, P., Brosnan, J.T. and Eggleston, L.V. 
(1970) in: Essays in Cell Metabolism (Bartley, W. et 
al. eds) pp.167-188, London. 
Meister, A. (1978) in: Glutamic Acid: Advances in 
Biochemistry and Physiology (Filer, L.J. et al. eds) 
pp.69-84, New York. 
Lanoue, K.F. and Schoolwerth, A.C. (1979) Annu. 
Rev. Biochem. 48, 871-922. 
Kovacevic, Z. and McGivan, J.D. (1983) Physiol. 
Rev. 63, 547-605. 
Shulman, R.G., Brown, T.R., Ugurbil, K., Ogawa, 
S., Cohen, S.M. and Den Hollander, J.A. (1979) 
Science 205, 160- 166. 
Bernard, M., Canioni, P. and Cozzone, P.J. (1983) 
Biochimie 65, 449-470. 
Cohen, SM., Ogawa, S., Rottenberg, H., Glynn, 
P. and Yamane, T. (1978) Nature 273, 554-556. 
Cohen, S.M., Glynn, P. and Shulman, R.G. (1981) 
Proc. Natl. Acad. Sci. USA 78, 60-64. 
Ogawa, S., Rottenberg, H., Brown, T.R., 
Shuiman, R.G., Castillo, C.M. and Glynn, P. 
(1978) Proc. Natl. Acad. Sci. USA 75, 1796-1800. 
Ogawa, S., Boens, C.C. and Lee, T.M. (1981) 
Arch. Biochem. Biophys. 210, 740-747. 
Cohen, S.M. (1983) J. Biol. Chem. 258, 
14294-14308. 
Salhany, J.M., Stohs, S.J., Reinke, L.A., Pieper, 
G.M. and Hassing, J.M. (1979) Biochem. Biophys. 
Res. Commun. 86, 1077-1083. 
Gordon, R.E., Hanley, P.E., Shaw, D., Gadian, 
D.G., Radda, G.K., Styles, P., Bore, P. J. and 
Chan, L. (1980) Nature 287, 736-738. 
Canioni, P., Alger, J.R. and Shulman, R.G. (1983) 
Biochemistry 22, 4974-4980. 
Haussinger, D. and Sies, H. (1979) Eur. J. Bio- 
them. 101, 179.-194. 
Lund, P. (1971) Biochem. J. 124, 653-660. 
Haussinger, D., Gerok, W. and Sies, H. (1983) Bio- 
chim. Biophys. Acta 755, 272---278. 
Haussinger, D. (1983) Eur. J. Biochem. 133, 
269-275. 
32 
